Doug Pace's appointment is a positive step for Dyadic's expansion in business development across core verticals. His biopharmaceutical expertise would facilitate Dyadic's leverage on C1 and Dapibus platforms to tap into the growing preventative, therapeutic biologic and alternative protein markets.
$DYAI — STOCK & OPTION PLAY NEED IT TO BREAK OVER: $5.23 key indicator for MORE uptrend $5.50 confirmation uptrend - $5.76 mini breakout - $5.83 full breakout - $5.98 SEMI PARABOLIC - $6.09 stop loss — $4.57 & support - $3.94.$Dyadic(DYAI.US)$
$DYAI — STOCK & OPTION PLAY NEED IT TO BREAK OVER: $5.50 key indicator for MORE uptrend $5.76 confirmation uptrend - $5.83 mini breakout - $5.98 full breakout - $6.09 SEMI PARABOLIC - $6.79 stop loss — $4.87 & support - $4.31.$Dyadic(DYAI.US)$
Dyadic股票討論區
DY-AI play no attention yet
NEED IT TO BREAK OVER: $5.23
key indicator for MORE uptrend $5.50
confirmation uptrend - $5.76
mini breakout - $5.83
full breakout - $5.98
SEMI PARABOLIC - $6.09
stop loss — $4.57
& support - $3.94. $Dyadic(DYAI.US)$
to the moon
NEED IT TO BREAK OVER: $5.50
key indicator for MORE uptrend $5.76
confirmation uptrend - $5.83
mini breakout - $5.98
full breakout - $6.09
SEMI PARABOLIC - $6.79
stop loss — $4.87
& support - $4.31. $Dyadic(DYAI.US)$
Play today and Tomorrow possibly watch toward end of day
$Athersys Inc(ATHX.US)$ $Dyadic(DYAI.US)$
$Sharps Compliance Corp(SMED.US)$
$Gaia Inc(GAIA.US)$
$Syndax Pharmaceuticals(SNDX.US)$
$Cytosorbents(CTSO.US)$
暫無評論